ES2077091T3 - 7-(difenilmetil)oxi-9a-metoximitosano y su obtencion y uso. - Google Patents

7-(difenilmetil)oxi-9a-metoximitosano y su obtencion y uso.

Info

Publication number
ES2077091T3
ES2077091T3 ES91103504T ES91103504T ES2077091T3 ES 2077091 T3 ES2077091 T3 ES 2077091T3 ES 91103504 T ES91103504 T ES 91103504T ES 91103504 T ES91103504 T ES 91103504T ES 2077091 T3 ES2077091 T3 ES 2077091T3
Authority
ES
Spain
Prior art keywords
metoximitosano
difenilmetil
oxi
obtaining
conversion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91103504T
Other languages
English (en)
Inventor
Daniel A Benigni
Kenton L Shultis
Henry She Lai Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2077091T3 publication Critical patent/ES2077091T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Polyesters Or Polycarbonates (AREA)

Abstract

7 PRODUCTO INTERMEDIO PARA LA CONVERSION EN 7 7 UNA REACCION PREFERENTE, EL COMPUESTO SE PREPARA A PARTIR DE MITOMICINA C A TRAVES DE 7 HIDROXI CAR (ELIMINACION DE AGUA). EL PRODUCTO INTERMEDIO SE CONVIERTE VENTAJOSAMENTE EN EL AGENTE ANTI (4 ALTOS INESPERADAMENTE UTILIZANDO UN PROCESO DE DOS ETAPAS DONDE LA PRIMERA CONSISTE EN LA CONVERSION 7 IO) ETILAMINO]
ES91103504T 1990-03-08 1991-03-07 7-(difenilmetil)oxi-9a-metoximitosano y su obtencion y uso. Expired - Lifetime ES2077091T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/491,380 US5075454A (en) 1990-03-08 1990-03-08 7-(diphenylmethyl)oxy-9a-methoxymitosane

Publications (1)

Publication Number Publication Date
ES2077091T3 true ES2077091T3 (es) 1995-11-16

Family

ID=23951969

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91103504T Expired - Lifetime ES2077091T3 (es) 1990-03-08 1991-03-07 7-(difenilmetil)oxi-9a-metoximitosano y su obtencion y uso.

Country Status (18)

Country Link
US (2) US5075454A (es)
EP (1) EP0445813B1 (es)
JP (1) JP2991348B2 (es)
KR (1) KR0152495B1 (es)
AT (1) ATE125811T1 (es)
AU (1) AU630022B2 (es)
CA (1) CA2037687C (es)
CY (1) CY1885A (es)
DE (1) DE69111640T2 (es)
DK (1) DK0445813T3 (es)
ES (1) ES2077091T3 (es)
FI (1) FI95260C (es)
GR (1) GR3017040T3 (es)
HK (1) HK4496A (es)
IE (1) IE68314B1 (es)
PT (1) PT96966B (es)
TW (1) TW219938B (es)
ZA (1) ZA911672B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495348B1 (en) 1993-10-07 2002-12-17 Regents Of The University Of Minnesota Mitomycin biosynthetic gene cluster
US6524812B1 (en) 1993-10-07 2003-02-25 Regents Of The University Of Minnesota Genes encoding resistance to DNA alkylating agents
US5703111A (en) * 1996-01-05 1997-12-30 Bristol-Myers Squibb Company Stable injectable formulation of BMY-25067
CA2208690A1 (en) * 1996-09-06 1998-03-06 James Robert Mccandless Package for compounding rubber, compounded rubber and tire having tread thereof
KR20180003312U (ko) 2017-05-16 2018-11-26 남송학 구근줄기 절단 및 선별 배출장치

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3306821A (en) * 1962-09-04 1967-02-28 Upjohn Co Porfiromycin derivatives and method of making same
US4059573A (en) * 1973-08-01 1977-11-22 Glaxo Laboratories Limited Extraction of N-blocked amino acids from aqueous media
JPS5840088A (ja) * 1981-09-04 1983-03-08 Kyowa Hakko Kogyo Co Ltd 発酵法によるマイトマイシンａの製造法
EP0116208B1 (en) * 1982-12-07 1988-03-30 Kyowa Hakko Kogyo Co., Ltd. Mitomycin analogues
US4803212A (en) * 1983-04-11 1989-02-07 Bristol-Myers Company Amino disulfides
US4691023A (en) * 1984-02-24 1987-09-01 Bristol-Myers Company Amino disulfides
JPS60255789A (ja) * 1984-06-01 1985-12-17 Kyowa Hakko Kogyo Co Ltd マイトマイシン誘導体，その製造法および抗腫瘍剤
US4814445A (en) * 1984-09-04 1989-03-21 Bristol-Myers Company Process for preparing mitomycin analogs
AU581673B2 (en) * 1984-09-04 1989-03-02 Bristol-Myers Company Substituted 7-oxomitosanes
US4866189A (en) * 1985-04-12 1989-09-12 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
US4720543A (en) * 1985-06-06 1988-01-19 Georgetown University 1a-7-substituted derivatives of mitomycin and uses thereof
US5023253A (en) * 1987-12-21 1991-06-11 University Patents, Inc. 6-substituted mitomycin analogs

Also Published As

Publication number Publication date
ZA911672B (en) 1991-11-27
ATE125811T1 (de) 1995-08-15
DE69111640T2 (de) 1996-01-25
US5075454A (en) 1991-12-24
KR0152495B1 (en) 1998-10-15
PT96966B (pt) 1998-07-31
TW219938B (es) 1994-02-01
FI95260B (fi) 1995-09-29
AU630022B2 (en) 1992-10-15
HK4496A (en) 1996-01-19
EP0445813B1 (en) 1995-08-02
JPH04211688A (ja) 1992-08-03
EP0445813A1 (en) 1991-09-11
KR910016754A (ko) 1991-11-05
US5352798A (en) 1994-10-04
AU7269891A (en) 1991-09-12
PT96966A (pt) 1991-10-31
FI95260C (fi) 1996-01-10
FI911184L (fi) 1991-09-09
IE910762A1 (en) 1991-09-11
CA2037687A1 (en) 1991-09-09
DE69111640D1 (de) 1995-09-07
IE68314B1 (en) 1996-06-12
FI911184A0 (fi) 1991-03-08
CY1885A (en) 1996-04-05
GR3017040T3 (en) 1995-11-30
JP2991348B2 (ja) 1999-12-20
DK0445813T3 (da) 1995-09-18
CA2037687C (en) 2001-10-30

Similar Documents

Publication Publication Date Title
AU554443B2 (en) 4-aminosalicylic acid as an anti-inflammatory agent
AU692387B2 (en) Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof
USD303949S (en) Vehicle wheel
CA2181172A1 (en) Storage-stable prostaglandin compositions
HUP9903174A2 (hu) Koenzim Q-10-et tartalmazó gyógyászati készítmény
EP0326196A3 (en) Aqueous pharmaceutical preparation
AU6421594A (en) High release solid preparation, preparation and use thereof
CA2141494A1 (en) Mediators suitable for the electrochemical regeneration of nadh, nadph or analogs thereof
AU3684895A (en) Use of human chorionic gonadotropin as an immune-potentiating agent
CA2115745A1 (en) Ester-free ethers
ITMI941868A0 (it) Derivati del 2-ammino-1,2,3,4-tetraidronaftalene attivi sul sistema cardiovascolare
GB2380939B (en) Treatment or prevention of auto-immune diseases
AU4926690A (en) Oxidized diphenylheteroalkanes, the preparation and use thereof
CA2386817A1 (en) The use of baclofen in the treatment of alcoholism
CO5190673A1 (es) Nueva composicion y uso liberacion modificada
IE821271L (en) Cyclohexane-1, 3-dione derivatives
CA2176223A1 (en) Fenbendazole formulations
DE69010025D1 (de) Verfahren zur Herstellung von 14-Alpha-hydroxy-4-androsten-3,6,17, trion.
EP0240431A3 (en) Process for the preparation of ethylenic carbonyl compounds
USD261933S (en) Spatula
EP0379940A3 (en) Glycidyl derivatives of 2,6-dibromo-3,5-dialkyl-4-hydroxybenzyl ethers
CA2309255A1 (en) Process for n-desmethylating erythromycins and derivatives thereof
USD298843S (en) Inflatable koala bear figure
AU4847390A (en) Fluorinated flavone acetic acid
CA2200930A1 (en) Process for preparing .alpha. -haloacetophenone derivative

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 445813

Country of ref document: ES